Syndrome of attention deficit with hyperactivity as the expression of an organic functional disorder;El síndrome de déficit de atención con hiperactividad como expresión de un trastorno funcional orgánico

Revista de Neurologia

Volumn 35, Issue 1, 2002, Pages 1-11

  Castellanos, Francisco Xavier ^a   Acosta, M T ^b  

^a NEW YORK UNIVERSITY CHILD STUDY CENTER   (United States)

^b GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

Author keywords

Basal ganglia; Dopamine; Evoked potentials; FMR; Magnetic resonance; Neuroanatomy; PET; SPECT; Syndrome of attention deficit with hyperactivity

Indexed keywords

ANAMNESIS; ATTENTION DEFICIT DISORDER; CEREBELLUM; CONFERENCE PAPER; CORPUS STRIATUM; HUMAN; HYPERACTIVITY; NUCLEAR MAGNETIC RESONANCE IMAGING; ORGANIC BRAIN SYNDROME; POSITRON EMISSION TOMOGRAPHY; PREFRONTAL CORTEX; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TRANSCRANIAL MAGNETIC STIMULATION; BIOLOGICAL MODEL; BRAIN; BRAIN LEVEL; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; ELECTROENCEPHALOGRAPHY; EVOKED RESPONSE; PATHOPHYSIOLOGY; REVIEW;

ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; BRAIN; BRAIN CHEMISTRY; ELECTROENCEPHALOGRAPHY; EVOKED POTENTIALS; HUMANS; MAGNETIC RESONANCE IMAGING; MODELS, BIOLOGICAL; TOMOGRAPHY, EMISSION-COMPUTED; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0036637189     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: 10.33588/rn.3501.2002231     Document Type: Conference Paper

References (132)

1. Tannock R. Attention deficit hyperactivity disorder: Advances in cognitive, neurobiological, and genetic research. J Child Psychol Psychiatry 1998; 39: 65-99.
2. Anderson JC, Williams S, McGee R, Silva PA. DSM-III disorders in preadolescent children. Prevalence in a large sample from the general population. Arch Gen Psychiatry 1987; 44: 69-76.
3. Wang YC, Chong MY, Chou WJ, Yang JL. Prevalence of attention deficit hyperactivity disorder in primary school children in Taiwan. J Formos Med Assoc 1993; 92: 133-8.
4. Fischer M, Barkley RA, Edelbrock CS, Smallish L. The adolescent outcome of hyperactive children diagnosed by research criteria: II. Academic, attentional, and neuropsychological status. J Consult Clin Psychol 1990; 58: 580-8.
5. Klein RG, Mannuzza S. Long-term outcome of hyperactive children: A review. J Am Acad Child Adolesc Psychiatry 1991; 30: 383-7.
6. World Health Organization. The ICD-10 Classification of Mental and Behavioural Disorders: Clinical Descriptions and Diagnostic Guidelines. Geneva, Switzerland: WHO; 1992.
7. World Health Organization. The ICD-10 classification of mental and behavioural disorders: Diagnostic criteria for research. Geneva, Switzerland: WHO; 1993.
8. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4 Ed. Washington, DC: American Psychiatric Association; 1994.
9. Swanson JM, Sergeant JA, Taylor E, Sonuga-Barke EJS, Jensen PS, Cantwell DP. Seminar: Attention-deficit hyperactivity disorder and hyperkinetic disorder. Lancet 1998; 351: 429-33.
10. Jensen PS, Martin D, Cantwell DP. Comorbidity in ADHD: Implications for research, practice, and DSM-V. J Am Acad Child Adolesc Psychiatry 1997; 36: 1065-79.
11. Sergeant J, Oosterlaan J, van der Meere J. Information processing and energetic factors in attention-deficit/hyperactivity disorder. In Quay HC, Hogan AE, eds. Handbook of Disruptive Behavior Disorders. New York: Plenum Press; 1999.
12. Jernigan TL, Tallal P. Late childhood changes in brain morphology observable with MRI. Dev Med Child Neurol 1990; 32: 379-85.
13. Jernigan TL, Trauner DA, Hesselink JR, Tallal PA. Maturation of human cerebrum observed in vivo during adolescence. Brain 1991; 114: 2037-49.
14. Sowell ER, Thompson PM, Holmes CJ, Jernigan TL, Toga AW. In vivo evidence for post-adolescent brain maturation in frontal and striatal regions. Nat Neurosci 1999; 2: 859-61.
15. Sowell ER, Thompson PM, Holmes CJ, Batth R, Jernigan TL, Toga AW. Localizing age-related changes in brain structure between childhood and adolescence using statistical parametric mapping. Neuroimage 1999; 9: 587-97.
16. Giedd JN, Snell JW, Lange N, Rajapakse JC, Casey BJ, Kozuch PL, et al. Quantitative magnetic resonance imaging of human brain development: Ages 4-18. Cereb Cortex 1996; 6: 551-60.
17. Reiss AL, Abrams MT, Singer HS, Ross JL, Denckla MB. Brain development, gender and IQ in children. A volumetric imaging study. Brain 1996; 119: 1763-74.
18. Giedd JN, Blumenthal J, Jeffries NO, Castellanos FX, Liu H, Zijdenbos A, et al. Brain development during childhood and adolescence: A longitudinal MRI study. Nat Neurosci 1999; 2: 861-3.
19. Paus T, Zijdenbos A, Worsley K, Collins DL, Blumenthal J, Giedd JN, et al. Structural maturation of neural pathways in children and adolescents: In vivo study. Science 1999; 283: 1908-11.
20. Huttenlocher PR. Synaptic density in human frontal cortex-developmental changes and effects of aging. Brain Res 1979; 163: 195-205.
21. Huttenlocher PR, Dabholkar AS. Regional differences in synaptogenesis in human cerebral cortex. J Comp Neurol 1997; 387: 167-78.
22. Giedd JN, Blumenthal J, Jeffries NO, Rajapakse JC, Vaituzis AC, Liu H, et al. Development of the human corpus callosum during childhood and adolescence: A longitudinal MRI study. Prog Neuropsychopharmacol Biol Psychiatry 1999; 23: 571-88.
23. Lange N, Giedd JN, Castellanos FX, Vaituzis AC, Rapoport JL. Variability of human brain structure size: Ages 4 to 20. Psychiatry Res Neuroimaging 1997; 74: 1-12.
24. Arndt S, Cohen G, Alliger RJ, Swayze VW, Andreasen NC. Problems with ratio and proportion measures of imaged cerebral structures. Psychiatry Res 1991; 40: 79-89.
25. Weinberger DR, Luchins DJ, Morihisa J, Wyatt RJ. Asymmetrical volumes of the right and left frontal and occipital regions of the human brain. Neurology 1982; 11: 97-100.
26. Shaywitz BA, Shaywitz SE, Byrne T, Cohen DJ, Rothman S. Attention deficit disorder: Quantitative analysis of CT. Neurology 1983; 33: 1500-3.
27. Hynd GW, Semrud-Clikeman M, Lorys AR, Novey ES, Eliopulos D. Brain morphology in developmental dyslexia and attention deficit disorder/hyperactivity. Arch Neurol 1990; 47: 919-26.
28. Castellanos FX, Giedd JN, Marsh WL, Hamburger SD, Vaituzis AC, Dickstein DP, et al. Quantitative brain magnetic resonance imaging in attention-deficit/hyperactivity disorder. Arch Gen Psychiatry 1996; 53: 607-16.
29. Filipek PA, Semrud-Clikeman M, Steingard RJ, Renshaw PF, Kennedy DN, Biederman J. Volumetric MRI analysis comparing attention-deficit hyperactivity disorder and normal controls. Neurology 1997; 48: 589-601.
30. Casey BJ, Castellanos FX, Giedd JN, Marsh WL, Hamburger SD, Schubert AB, et al. Implication of right frontostriatal circuitry in response inhibition and attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 1997; 36: 374-83.
31. Yeo RA, Hill D, Campbell R, Brooks WM, Zamora L. A proton magnetic resonance spectroscopy investigation of the right frontal lobe in children with attention deficit hyperactivity disorder. J Cogn Neurosci 2000; (Suppl): 64.
32. Overmeyer S, Bullmore ET, Suckling J, Simmons A, Williams SCR, Santosh PJ, et al. Distributed grey and white matter deficits in hyperkinetic disorder: MRI evidence for anatomical abnormality in an attentional network. Psychol Med 2001; 31: 1425-35.
33. Pontius AA. Dysfunction patterns analogous to frontal lobe system and caudate nucleus syndromes in some groups of minimal brain dysfunction. J Am Med Wom Assoc 1973; 28: 285-92.
34. Hynd GW, Hem KL, Novey ES, Eliopulos D, Marshall R, González JJ, et al. Attention deficit hyperactivity disorder and asymmetry of the caudate nucleus. J Child Neurol 1993; 8: 339-47.
35. Mataró M, García-Sánchez C, Junqué C, Estévez-González A, Pujol J. Magnetic resonance imaging measurement of the caudate nucleus in adolescents with attention-deficit hyperactivity disorder and its relationship with neuropsychological and behavioral measures. Arch Neurol 1997; 54: 963-8.
36. Castellanos FX, Giedd JN, Berquin PC, Walter JM, Sharp W, Tran T, et al. Quantitative brain magnetic resonance imaging in girls with attention-deficit/hyperactivity disorder. Arch Gen Psychiatry 2001; 58: 289-95.
37. Aylward EH, Reiss AL, Reader MJ, Singer HS, Brown JE, Denckla MB. Basal ganglia volumes in children with attention-deficit hyperactivity disorder. J Child Neurol 1996; 11: 112-5.
38. Teicher MH, Anderson CM, Polcari A, Glod CA, Maas LC, Renshaw PF. Functional deficits in basal ganglia of children with attention-deficit/hyperactivity disorder shown with functional magnetic resonance imaging relaxometry. Nat Med 2000; 6: 470-3.
39. Max JE, Arndt S, Castillo CS, Bokura H, Robin DA, Lindgren SD, et al. Attention-deficit hyperactivity symptomatology after traumatic brain injury: A prospective study. J Am Acad Child Adolesc Psychiatry 1998; 37: 841-7.
40. Herskovits EH, Megalooikonomou V, Davatzikos C, Chen A, Bryan RN, Gerring JP. Is the spatial distribution of brain lesions associated with closed-head injury predictive of subsequent development of attention-deficit/hyperactivity disorder? Analysis with brain-image database. Radiology 1999; 213: 389-94.
41. Nasrallah HA, Loney J, Olson SC, McCalley-Whitters M, Kramer J, Jacoby CG. Cortical atrophy in young adults with a history of hyperactivity in childhood. Psychiatry Res 1986; 17: 241-6.
42. Berquin PC, Giedd JN, Jacobsen LK, Hamburger SD, Krain AL, Rapoport JL, et al. The cerebellum in attention-deficit/hyperactivity disorder: A morphometric study. Neurology 1998; 50: 1087-93.
43. Mostofsky SH, Reiss AL, Lockhart P, Denckla MB. Evaluation of cerebellar size in attention-deficit hyperactivity disorder. J Child Neurol 1998; 13: 434-9.
44. Jacobsen LK, Giedd JN, Berquin PC, Krain AL, Hamburger SD, Kumra S, et al. Quantitative morphology of the cerebellum and fourth ventricle in childhood-onset schizophrenia. Am J Psychiatry 1997; 154: 1663-9.
45. DelBello MP, Strakowski SM, Zimmerman ME, Hawkins JM, Sax KW. MRI analysis of the cerebellum in bipolar disorder: A pilot study. Neuropsychopharmacology 1999; 21: 63-8.
46. Melchitzky DS, Lewis DA. Tyrosine hydroxylase- and dopamine transporter-immunoreactive axons in the primate cerebellum. Evidence for a lobular-and laminar-specific dopamine innervation. Neuropsychopharmacology 2000; 22: 466-72.
47. Snider RS, Maiti A, Snider SR. Cerebellar pathways to ventral midbrain and nigra. Exp Neurol 1976; 53: 714-28.
48. Dempesy CW, Tootle DM, Fontana CJ, Fitzjarrell AT, Garey RE, Heath RG. Stimulation of the paleocerebellar cortex of the cat: Increased rate of synthesis and release of catecholamines at limbic sites. Biol Psychiatry 1983; 18: 127-32.
49. Anderson CM, Polcari AM, McGreenery CE, Maas LC, Renshaw PF, Teicher MH. Cerebellar vermis blood flow: Associations with psychiatric symptoms in child abuse and ADHD. Society for Neuroscience Abstracts 1999; 25: 1637
50. Ernst M, Zametkin AJ, Matochik JA, Schmidt ME, Jons PH, Liebenauer LL, et al. Intravenous dextroamphetamine and brain glucose metabolism. Neuropsychopharmacology 1997; 17: 391-401.
51. Volkow ND, Wang GJ, Fowler JS, Logan J, Angrist B, Hitzemann R, et al. Effects of methylphenidate on regional brain glucose metabolism in humans: Relationship to dopamine D2 receptors. Am J Psychiatry 1997; 154: 50-5.
52. Schweitzer JB, Lee DO, Ely TD, Grafton ST, Ostrowitz M, Hanford RB, et al. The effects of methylphenidate on the functional neuroanatomy of working memory in ADHD. Society for Neuroscience Abstracts 1998;24:958.
53. Alexander GE, DeLong MR, Strick PL. Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annu Rev Neurosci 1986; 9: 357-81.
54. Graybiel AM. The basal ganglia and chunking of action repertoires. Neurobiol Learn Mem 1998; 70: 119-36.
55. Jueptner M, Wéiller C. A review of differences between basal ganglia and cerebellar control of movements as revealed by functional imaging studies. Brain 1998; 121: 1437-49.
56. Bradley DJ, Ghelarducci B, Spyer KM. The role of the posterior cerebellar vermis in cardiovascular control. Neurosci Res 1991; 12: 45-56.
57. Ghelarducci B, Sebastiani L. Classical heart rate conditioning and affective behavior: The role of the cerebellar vermis. Arch Ital Biol 1997; 135: 369-84.
58. Van der Meere JJ. The role of attention in hyperactivity disorders. In Sandberg S, ed. Hyperactivity and Attention Disorders of Childhood. Cambridge: Cambridge University Press; 2002.
59. Jennings JR, van der Molen MW, Pelham W, Debski KB, Hoza B. Inhibition in boys with attention deficit hyperactivity disorder as indexed by heart rate change. Dev Psychol 1997; 33: 308-18.
60. Borger N, van der Meere J. Motor control and state regulation in children with ADHD: A cardiac response study. Biol Psychol 2000; 51: 247-67.
61. Draeger S, Prior M, Sanson A. Visual and auditory attention performance in hyperactive children: Competence or compliance. J Abnorm Child Psychol 1986; 14: 411-24.
62. Zametkin AJ, Nordahl TE, Gross M, King AC, Semple WE, Rumsey J, et al. Cerebral glucose metabolism in adults with hyperactivity of childhood onset. N Engl J Med 1990; 323: 1361-6.
63. Zametkin AJ, Liebenauer LL, Fitzgerald GA, King AC, Minkunas DV, Herscovitch P, et al. Brain metabolism in teenagers with attention-deficit hyperactivity disorder. Arch Gen Psychiatry 1993; 50: 333-40.
64. Ernst M, Liebenauer LL, King AC, Fitzgerald GA, Cohen RM, Zametkin AJ. Reduced brain metabolism in hyperactive girls. J Am Acad Child Adolesc Psychiatry 1994; 33: 858-68.
65. Ernst M, Cohen RM, Liebenauer LL, Jons PH, Zametkin AJ. Cerebral glucose metabolism in adolescent girls with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 1997; 36: 1399-406.
66. Ernst M, Zametkin AJ, Matochik JA, Jons PH, Cohen RM. DOPA decarboxylase activity in attention deficit hyperactivity disorder adults. A [fluorine-18] fluorodopa positron emission tomographic study. J Neurosci 1998; 18: 5901-7.
67. Ernst M, Zametkin AJ, Matochik JA, Pascualvaca D, Jons PH, Cohen RM. High midbrain 18F-DOPA accumulation in children with ADHD. Am J Psychiatry 1999; 156: 1209-15.
68. Lou HC, Henriksen L, Bruhn P. Focal cerebral dysfunction in developmental learning disabilities. Lancet 1990; 335: 8-11.
69. Amen DG, Paldi JH, Thisted RA. Brain SPECT imaging. J Am Acad Child Adolesc Psychiatry 1993; 32: 1080-1.
70. Bandettini PA, Kwong KK, Davis TL, Tootell RB, Wong EC, Fox PT, et al. Characterization of cerebral blood oxygenation and flow changes during prolonged brain activation. Hum Brain Mapp 1997; 5: 93-109.
71. Vaidya CJ, Austin G, Kirkorian G, Ridlehuber HW, Desmond JE, Glover GH, et al. Selective effects of methylphenidate in attention deficit hyperactivity disorder: A functional magnetic resonance imaging study. Proc Natl Acad Sci U S A 1998; 95: 14494-9.
72. Rapoport JL, Buchsbaum MS, Zahn TP, Weingartner H, Ludlow C, Mikkelsen EJ. Dextroamphetamine: Cognitive and behavioral effects in normal prepubertal boys. Science 1978; 199: 560-3.
73. Meador-Woodruff JH, Damask SP, Watson SJ Jr. Differential expression of autoreceptors in the ascending dopamine systems of the human brain. Proc Natl Acad Sci U S A 1994; 91: 8297-301.
74. Frazer A, Gerhardt GA, Daws LC. New views of biogenic amine transporter function: Implications for neuropsychopharmacology. Int J Neuropsychopharmacol 1999; 2: 305-20.
75. Volkow ND, Wang GJ, Fowler JS, Hitzemann R, Gatley J, Ding YS, et al. Differences in regional brain metabolic responses between single and repeated doses of methylphenidate. Psychiatry Res 1998; 83: 29-36.
76. Rubia K, Overmeyer S, Taylor E, Brammer M, Williams SC, Simmons A, et al. Hypofrontality in attention deficit hyperactivity disorder during higher-order motor control: A study with functional MRI. Am J Psychiatry 1999; 156: 891-6.
77. Schachar RJ, Tannock R. Inhibitory control, impulsiveness, and attention deficit hyperactivity disorder. Clin Psychol Rev 1993; 13: 721-39.
78. Levy F. The development of sustained attention (vigilance) and inhibition in children: Some normative data. J Child Psychol Psychiatry 1980; 21: 77-84.
79. Bush G, Frazier JA, Rauch SL, Seidman LJ, Whalen PJ, Jenike MA, et al. Anterior cingulate cortex dysfunction in attention-deficit/hyperactivity disorder revealed by fMRI and the counting Stroop. Biol Psychiatry 1999; 45: 1542-52.
80. Bush G, Whalen PJ, Rosen BR, Jenike MA, McInerney SC, Rauch SL. The counting Stroop: An interference task specialized for functional neuroimaging-validation study with functional MRI. Hum Brain Mapp 1998; 6: 270-82.
81. 2-relaxation time measures correlate with gadolinium-based cerebral blood volume estimates in the putamen and cerebellar vermis of young adults. Soc Neurosci Abstr 2000; 27: 1730.
82. Anderson CM, Polcari AM, McGreenery CE, Maas LC, Renshaw PF, Teicher MH. Methylphenidate dose-dependently alters blood flow in the vermis but not basal ganglia of ADHD boys. Biol Psychiatry 2000; 47: 106-7.
83. Albert TJ, Dempesy CW, Sorenson CA. Anterior cerebellar vermal stimulation: Effect on behavior and basal forebrain neurochemistry in rat. Biol Psychiatry 1985; 20: 1267-76.
84. Snider RS, Maiti A. Cerebellar contributions to the Papez circuit. J Neurosci Res 1976; 2: 133-46.
85. Heath RG, Dempesy CW, Fontana CJ, Myers WA. Cerebellar stimulation: Effects on septal region, hippocampus, and amygdala of cats and rats. Biol Psychiatry 1978; 13: 501-29.
86. Heath RG, Dempesy CW, Fontana CJ, Fitzjarrell AT. Feedback loop between cerebellum and septal-hippocampal sites: Its role in emotion and epilepsy. Biol Psychiatry 1980; 15: 541-56.
87. Schmahmann JD, Sherman JC. The cerebellar cognitive affective syndrome. Brain 1998; 121: 561-79.
88. Supple WF Jr, Kapp BS. Anatomical and physiological relationships between the anterior cerebellar vermis and the pontine parabrachial nucleus in the rabbit. Brain Res Bull 1994; 33: 561-74.
89. Castellanos FX. Toward a pathophysiology of attention-deficit/hyperactivity disorder. Clin Pediatr 1997; 36: 381-93.
90. Dougherty DD, Bonab AA, Spencer TJ, Rauch SL, Madras BK, Fischman AJ. Dopamine transporter density is elevated in patients with attention deficit hyperactivity disorder. Lancet 1999; 354: 2132-3.
91. Baughman FA. Dopamine-transporter density in patients with ADHD (letter). Lancet 2000; 355: 1460-1.
92. Krause KH, Dresel SH, Krause J, Kung HF, Tatsch K. Increased striatal dopamine transporter in adult patients with attention deficit hyperactivity disorder: Effects of methylphenidate as measured by single photon emission computed tomography. Neurosci Lett 2000; 285: 107-10.
93. van Dyck CH, Quinlan DM, Cretella LM, Staley JK, Malison RT, Baldwin RM, et al. Unaltered dopamine transporter availability in adult attention deficit hyperactivity disorder. Am J Psychiatry 2002; 159: 309-12.
94. Lou HC, Andresen J, Steinberg B, McLaughlin T, Friberg L. The striatum in a putative cerebral network activated by verbal awareness in normal and in ADHD children. Eur J Neurol 1998; 5: 67-74.
95. Cass WA, Gerhardt GA. In vivo assessment of dopamine uptake in rat medial prefrontal cortex: Comparison with dorsal striatum and nucleus accumbens. J Neurochem 1995; 65: 201-7.
96. Koepp MJ, Gunn RN, Lawrence AD, Cunningham VJ, Dagher A, Jones T, et al. Evidence for striatal dopamine release during a video game. Nature 1998; 393: 266-8.
97. Moll GH, Heinrich H, Trott G, Wirth S, Rothenberger A. Deficient intracortical inhibition in drug-naive children with attention-deficit hyperactivity disorder is enhanced by methylphenidate. Neurosci Lett 2000; 284: 121-5.
98. Nogueira de Melo A, Niedermeyer E. The EEG in infantile brain damage, cerebral palsy, and minor cerebral dysfunctions of childhood. In Niedermeyer E, Lopes da Silva FH, eds. Electroencephalography: Basic Principles, Clinical Applications, and Related Fields. Baltimore: Williams & Wilkins; 1999.
99. Nuwer MR. Assessing digital and quantitative EEG in clinical settings. J Clin Neurophysiol 1998; 15: 458-63.
100. Nuwer M. Assessment of digital EEG, quantitative EEG, and EEG brain mapping: Report of the American Academy of Neurology and the American Clinical Neurophysiology Society. Neurology 1997; 49: 277-92.
101. Levy F, Ward PB. Neurometrics, dynamic brain imaging and attention deficit hyperactivity disorder. J Paediatr Child Health 1995; 31: 279-83.
102. Monastra VJ, Lubar JF, Linden M, van Deusen P, Green G, Wing W, et al. Assessing attention deficit hyperactivity disorder via quantitative electroencephalography: An initial validation study. Neuropsychology 1999; 13: 424-33.
103. Monastra VJ, Lubar JF, Linden M. The development of a QEEG scanning process for ADHD: Reliability and validity studies. Neuropsychology 2000; 15: 136-44.
104. Lazzaro I, Gordon E, Li W, Lim CL, Plahn M, Whitmont S, et al. Simultaneous EEG and EDA measures in adolescent attention deficit hyperactivity disorder. Int J Psychophysiol 1999; 34: 123-34.
105. Satterfield JH, Cantwell DP, Satterfield BT. Pathophysiology of the hyperactive child syndrome. Arch Gen Psychiatry 1974; 31: 839-44.
106. Klorman R. Cognitive event-related potentials in attention deficit disorder. J Learn Disabil 1991; 24: 130-40.
107. Heinrich H, Dickhaus H, Rothenberger A, Heinrich V, Moll GH. Single-sweep analysis of event-related potentials by wavelet networks-methodological basis and clinical application. IEEE Trans Biomed Eng 1999; 46: 867-79.
108. Lazzaro I, Anderson J, Gordon E, Clarke S, Leong J, Meares R. Single trial variability within the P300 (250-500 ms) processing window in adolescents with attention deficit hyperactivity disorder. Psychiatry Res 1997; 73: 91-101.
109. Silberstein RB, Farrow M, Levy F, Pipingas A, Hay DA, Jarman FC. Functional brain electrical activity mapping in boys with attention-deficit/hyperactivity disorder. Arch Gen Psychiatry 1998; 55: 1105-12.
110. Morgan ST, Hansen JC, Hillyard SA. Selective attention to stimulus location modulates the steady-state visual evoked potential. Proc Natl Acad Sci U S A 1996; 93: 4770-4.
111. Baving L, Laucht M, Schmidt MH. Atypical frontal brain activation in ADHD: Preschool and elementary school boys and girls. J Am Acad Child Adolesc Psychiatry 1999; 38: 1363-71.
112. Pliszka SR, Liotti M, Woldorff MG. Inhibitory control in children with attention-deficit/hyperactivity disorder: Event-related potentials identify the processing component and timing of an impaired right-frontal response- inhibition mechanism. Biol Psychiatry 2000; 48: 238-46.
113. Cox DJ, Kovatchev BP, Morris JB Jr, Phillips C, Hill RJ, Merkel L. Electroencephalographic and psychometric differences between boys with and without attention-deficit/Hyperactivity disorder (ADHD): A pilot study. Appl Psychophysiol Biofeedback 1998; 23: 179-88.
114. Cox DJ, Kalbfleisch ML, Kovatchev B, Merkel L, Loboschefski T, Robeva R, et al. Quantitative assessment of attention-deficit hyperactivity disorder: Validation of the EEG consistency index & patterns of creative performance. J Cogn Neurosci 2000; 102.
115. Wender PH. Some speculations concerning a possible biochemical basis of minimal brain dysfunction. Ann N Y Acad Sci 1973; 205: 18-28.
116. Pliszka SR, McCracken JT, Maas JW. Catecholamines in attention-deficit hyperactivity disorder: Current perspectives. J Am Acad Child Adolesc Psychiatry 1996; 35: 264-72.
117. Roth RH, Elsworth JD. Biochemical pharmacology of midbrain dopamine neurons. In Bloom FE, Kupfer DJ, eds. Psychopharmacology: The Fourth Generation of Progress. New York: Raven Press; 1995.
118. Arnsten AF, Steere JC, Hunt RD. The contribution of alpha 2-noradrenergic mechanisms of prefrontal cortical cognitive function. Potential significance for attention-deficit hyperactivity disorder. Arch Gen Psychiatry 1996; 53: 448-55.
119. Aston-Jones G, Rajkowski J, Cohen J. Role of locus coeruleus in attention and behavioral flexibility. Biol Psychiatry 1999; 46: 1309-20.
120. Berridge CW. Arousal-and attention-related actions of the locus coeruleus-noradrenergic system: Potential target in the therapeutic actions of amphetamine-like stimulants. In Solanto MV, Arnsten AFT, Castellanos FX, eds. Stimulant Drugs and ADHD: Basic and Clinical Neuroscience. New York: Oxford University Press; 2001.
121. Rajkowski J, Kubiak P, Aston-Jones G. Locus coeruleus activity in monkey: Phasic and tonic changes are associated with altered vigilance. Brain Res Bull 1994; 35: 607-16.
122. Usher M, Cohen JD, Servan-Schreiber D, Rajkowski J, Aston-Jones G. The role of locus coeruleus in the regulation of cognitive performance. Science 1999; 283: 549-54.
123. Civelli O. Molecular biology of the dopamine receptor subtypes. In Bloom FE, Kupfer DJ, eds. Psychopharmacology: The Fourth Generation of Progress. New York: Raven Press; 1995.
124. Sunahara RK, Seeman P, van Tol HH, Niznik HB. Dopamine receptors and antipsychotic drug response. Br J Psychiatry 1993; 163 (Suppl 22): 31-8.
125. Seeman P. Dopamine receptors. Clinical correlates. In Bloom FE, Kupfer DJ, eds. Psychopharmacology: The Fourth Generation of Progress. New York: Raven Press; 1995.
126. Meador-Woodruff JH, Damask SP, Wang J, Haroutunian V, Davis KL, Watson SJ. Dopamine receptor mRNA expression in human striatum and neocortex. Neuropsychopharmacology 1996; 15: 17-29.
127. Lidow MS, Wang F, Cao Y, Goldman-Rakic PS. Layer V neurons bear the majority of mRNAs encoding the five distinct dopamine receptor subtypes in the primate prefrontal cortex. Synapse 1998; 28: 10-20.
128. 4 receptors in GABAergic neurons of the primate brain. Nature 1996; 381: 245-8.
129. Ariano MA, Wang J, Noblett KL, Larson ER, Sibley DR. Cellular distribution of the rat D4 dopamine receptor protein in the CNS using anti-receptor antisera. Brain Res 1997; 752: 26-34.
130. Swanson JM, Flodman P, Kennedy J, Spence MA, Moyzis R, Schuck S, et al. Dopamine genes and ADHD. Neurosci Biobehav Rev 2000; 24: 21-5.
131. Snider RS, Maiti A, Snider SR. Cerebellar connections to catecholamine systems: Anatomical and biochemical studies. Trans Am Neurol Assoc 1976; 101: 295-7.
132. Castellanos FX, Elia J, Kruesi MJP, Marsh WL, Gulotta CS, Potter WZ, et al. Cerebrospinal homovanillic acid predicts behavioral response to stimulants in 45 boys with attention-deficit/hyperactivity disorder. Neuropsychopharmacology 1996; 14: 125-37.